SIRT7 and neoplasm: In breast cancer cells, SIRT7 deacetylates SMAD4 and facilitates its degradation, which inhibits TGF-β signaling and subsequent breast cancer invasion and migration [57], which is possibily associated with tumor angiogenesis.